Musculo-skeletal system agent
DG03232 Osteoporosis agent
Remark
Therapeutic category:
3999
ATC code:
M05BX01
Product:
D01338<JP>
Efficacy
Osteoporosis agent
Comment
synthetic isoflavone
Interaction
Structure map
map07047
Osteoporosis drugs
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BX Other drugs affecting bone structure and mineralization
M05BX01 Ipriflavone
D01338 Ipriflavone (JP18/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D01338 Ipriflavone (JP18/INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D01338 Ipriflavone
Drug classes [BR:br08332]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D01338 Ipriflavone
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01338 Ipriflavone
D01338 Ipriflavone tablets
Other DBs
CAS:
35212-22-7
PubChem:
7848401
ChEBI:
31719
LigandBox:
D01338
NIKKAJI:
J19.468I
KCF data
ATOM 21
1 C8y C 24.3560 -17.0585
2 C8y C 25.5654 -16.3618
3 C8x C 25.5654 -14.9615
4 O2x O 24.3560 -14.2577
5 C8y C 23.1392 -16.3618
6 C8y C 23.1392 -14.9615
7 C8x C 21.9256 -14.2577
8 C8y C 20.7117 -14.9615
9 C8x C 20.7117 -16.3618
10 C8x C 21.9256 -17.0585
11 O5x O 24.3576 -18.4590
12 C8y C 26.7797 -17.0577
13 C8x C 26.7782 -18.4514
14 C8x C 27.9855 -19.1541
15 C8x C 29.1988 -18.4495
16 C8x C 29.1976 -17.0490
17 C8x C 27.9835 -16.3534
18 O2a O 19.4981 -14.2577
19 C1c C 18.2913 -14.9615
20 C1a C 17.0777 -14.2577
21 C1a C 18.2913 -16.3618
BOND 23
1 10 5 1
2 1 11 2
3 5 1 1
4 2 12 1
5 1 2 1
6 2 3 2
7 3 4 1
8 4 6 1
9 5 6 2
10 12 13 2
11 13 14 1
12 14 15 2
13 15 16 1
14 16 17 2
15 17 12 1
16 6 7 1
17 8 18 1
18 7 8 2
19 18 19 1
20 8 9 1
21 19 20 1
22 9 10 2
23 19 21 1